Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

22.05.12	Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO (Businesswire)
18.05.12	Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients (Businesswire)
15.05.12	Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC) (Businesswire)
14.05.12	Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting (Businesswire)
10.05.12	Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference (Businesswire)
09.05.12	FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (Businesswire)
07.05.12	Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults (Businesswire)
04.05.12	Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy (Businesswire)
04.05.12	Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy (Businesswire)
02.05.12	Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™ (taliglucerase alfa) For The Treatment Of Gaucher Disease (Businesswire)
01.05.12	Pfizer Reports First-Quarter 2012 Results (Businesswire)
01.05.12	Pfizer Inc. Issues Statement Regarding Pending Court Case (Businesswire)
26.04.12	Pfizer Hosts Annual Meeting Of Shareholders (Businesswire)
25.04.12	The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program (Businesswire)
23.04.12	Pfizer To Divest Nutrition Business To Nestlé (Businesswire)
19.04.12	Pfizer Invites Public To Listen To Webcast Of April 26 Annual Meeting Of Shareholders (Businesswire)
18.04.12	The Advil® Congestion Relief Project Visits Dayton To Relieve Community Center Congestion Allowing More Students To Participate In Local Mentorship Program (Businesswire)
11.04.12	The Advil® Congestion Relief Project Relieves Transportation Congestion in Albany to Help Get Students to Afterschool Programs (Businesswire)
09.04.12	"MasterChef” Judge Joe Bastianich Cooks With "Heart” At New Chicago Walgreens Flagship Store (Businesswire)
27.03.12	Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts (Businesswire)
26.03.12	Pfizer to Present New Data Highlighting Ongoing Research at 2012 Meeting of the American Association for Cancer Research (Businesswire)
13.03.12	Biocon And Pfizer Conclude Commercialization Agreement (Businesswire)
12.03.12	Pfizer’s Prevnar 13® Shown to be Immunogenic in Older Children and Adolescents (Businesswire)
06.03.12	Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference (Businesswire)
28.02.12	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
27.02.12	Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company (Businesswire)
22.02.12	Pfizer Statement Regarding CDC’s ACIP Discussion of Prevnar 13® for Use in Adults (Businesswire)
17.02.12	Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines (Businesswire)
15.02.12	FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) (Businesswire)
01.02.12	Pfizer Issues Statement On Voluntary Recall (Businesswire)
31.01.12	Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance (Businesswire)
27.01.12	U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) (Businesswire)
27.01.12	Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia (Businesswire)
26.01.12	Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care (Businesswire)
17.01.12	Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer’s Disease (Businesswire)
10.01.12	Introducing nutritionpossible.com – A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health (Businesswire)
03.01.12	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
22.12.11	Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms (Businesswire)
20.12.11	Fort Myers Regional Partnership Announces Expansion of Chico’s FAS Corporate Headquarters (Businesswire)
20.12.11	Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts (Businesswire)
20.12.11	Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis (Businesswire)
16.12.11	Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome (Businesswire)
16.12.11	Molycorp Secures Government Approval To Conduct Heavy Rare Earth Exploratory Drilling (Businesswire)
16.12.11	Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries (Businesswire)
13.12.11	New Survey Reveals Top Misperceptions Parents Have When Treating Their Child’s Fever (Businesswire)
12.12.11	Pfizer Elects CEO Ian Read As Chairman Of The Board (Businesswire)
12.12.11	Pfizer Declares A 22-Cent First-Quarter 2012 Dividend (Businesswire)
09.12.11	Jon Bon Jovi Reveals His True Advil® Story (Businesswire)
08.12.11	The Advil® Congestion Relief Project Tackles Congestion in Chicago, the Country’s #1 City for Traffic Congestion* (Businesswire)
07.12.11	FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC) To Be Favorable (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

16:16		EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert
16:12		Roche-Aktie unbeeindruckt: Roche bringt neuen Test zur präziseren Leberfibrose-Diagnose auf den Markt
16:02		Dow Jones 30 Industrial-Wert Merck-Aktie: So viel Gewinn hätte ein Merck-Investment von vor 10 Jahren eingefahren
16:02		S&P 500-Papier Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 10 Jahren verloren
10:02		EURO STOXX 50-Wert Sanofi-Aktie: So viel Verlust hätte eine Investition in Sanofi von vor 3 Jahren bedeutet
10:02		TecDAX-Papier EVOTEC SE-Aktie: So viel Verlust hätte ein Investment in EVOTEC SE von vor 3 Jahren bedeutet
05.05.25		DAX 40-Papier Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor einem Jahr eingebracht
05.05.25		SMI-Papier Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 10 Jahren abgeworfen

16:16

EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert

16:12

Roche-Aktie unbeeindruckt: Roche bringt neuen Test zur präziseren Leberfibrose-Diagnose auf den Markt

16:02

Dow Jones 30 Industrial-Wert Merck-Aktie: So viel Gewinn hätte ein Merck-Investment von vor 10 Jahren eingefahren

16:02

S&P 500-Papier Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 10 Jahren verloren

10:02

EURO STOXX 50-Wert Sanofi-Aktie: So viel Verlust hätte eine Investition in Sanofi von vor 3 Jahren bedeutet

10:02

TecDAX-Papier EVOTEC SE-Aktie: So viel Verlust hätte ein Investment in EVOTEC SE von vor 3 Jahren bedeutet

05.05.25

DAX 40-Papier Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor einem Jahr eingebracht

05.05.25

SMI-Papier Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 10 Jahren abgeworfen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swisscom	551.00	1.01 %	K V
Nestle	88.16	0.94 %	K V
Swiss Re	152.30	0.83 %	K V
Swiss Life Hldg	846.00	0.52 %	K V
Zurich Insur Gr	593.60	0.37 %	K V
Sonova Hldg	254.30	-1.20 %	K V
Alcon	79.64	-1.29 %	K V
Logitech Intl	63.44	-1.34 %	K V
ABB	44.69	-1.54 %	K V
Kuehne+Nagel Int	187.95	-2.08 %	K V

Pfizer Aktie VALOR 962004 / ISIN US7170811035

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten